
Laboratory testing forms the foundation of evidence-based functional medicine practice. Whilst conventional medicine relies on a relatively narrow panel of markers — primarily to diagnose established disease — functional medicine utilises a broader range of assessments to identify metabolic imbalances, nutritional insufficiencies, and physiological dysfunction before they progress to frank pathology.
The distinction between "normal" and "optimal" ranges is central to functional medicine interpretation. A patient whose vitamin D level of 52 nmol/L falls within the conventional reference range (>50 nmol/L) may still be functionally insufficient, given that optimal immune and metabolic function typically requires levels between 75-125 nmol/L. This nuanced interpretation, grounded in evidence from clinical trials and epidemiological data, distinguishes functional medicine testing from routine screening.
Beyond standard glucose and HbA1c, fasting insulin provides critical early insight into metabolic health. Insulin resistance precedes glucose dysregulation by years, making fasting insulin (optimal range: 3-8 mIU/L) an essential screening tool. The HOMA-IR calculation (fasting insulin x fasting glucose / 22.5) quantifies insulin resistance with values above 1.5 warranting clinical attention.
Standard TSH-only screening misses subclinical thyroid dysfunction. A comprehensive panel should include TSH, free T4, free T3, reverse T3, TPO antibodies, and thyroglobulin antibodies. The free T3 to reverse T3 ratio (optimal >0.2 when using pg/mL and ng/dL units respectively) identifies peripheral conversion issues that TSH alone cannot detect.
Ferritin alone is insufficient for comprehensive iron assessment. A complete panel includes serum iron, TIBC (total iron-binding capacity), transferrin saturation, and ferritin. Ferritin is an acute-phase reactant — elevated levels may reflect inflammation rather than adequate iron stores. Optimal ferritin for premenopausal women: 50-100 ng/mL; for men and postmenopausal women: 75-150 ng/mL.
hs-CRP provides a sensitive measure of systemic inflammation, with optimal levels below 1.0 mg/L. Combined with ESR, homocysteine (optimal: 6-8 umol/L), and fibrinogen, these markers create a comprehensive inflammatory profile. Serial monitoring enables practitioners to track the effectiveness of anti-inflammatory dietary and lifestyle interventions objectively.
25-hydroxyvitamin D (optimal: 75-125 nmol/L), active B12 (holotranscobalamin), red blood cell folate, red blood cell magnesium, and zinc provide baseline nutritional status. Serum B12 measurements alone are unreliable — up to 50% of patients with normal serum B12 may have functional B12 deficiency detectable only through methylmalonic acid or active B12 testing.
The organic acids test analyses metabolic intermediates in urine, providing insight into mitochondrial function, neurotransmitter metabolism, detoxification capacity, and microbial overgrowth. Key markers include citric acid cycle intermediates (assessing mitochondrial efficiency), hippuric acid and D-arabinitol (indicating bacterial and fungal overgrowth), and markers of oxalate metabolism.
OAT results guide targeted supplementation — for example, elevated methylmalonic acid and formiminoglutamic acid point to B12 and folate insufficiency respectively, whilst elevated 3-hydroxypropionic acid suggests biotin deficiency or propionibacterium overgrowth.
Modern stool analysis combines PCR-based pathogen detection, commensal bacterial profiling, digestive function markers (elastase, steatocrit), inflammation markers (calprotectin, lactoferrin), and immunological markers (secretory IgA). This comprehensive assessment directly informs 5R gut protocol interventions, identifying whether the clinical priority is pathogen removal, digestive support, microbial rebalancing, or mucosal repair.
The DUTCH (Dried Urine Test for Comprehensive Hormones) panel provides a detailed picture of adrenal and sex hormone metabolism, including cortisol patterns, cortisol metabolites, oestrogen metabolites (2-OH, 4-OH, 16-OH pathways), and androgen metabolites. This level of detail enables practitioners to identify not only hormonal imbalances but the specific metabolic pathways driving them — critical for targeted intervention.
Single-nucleotide polymorphism (SNP) testing for clinically relevant genes — including MTHFR, COMT, VDR, APOE, FUT2, and CYP450 variants — provides a genetic context for personalised supplementation and dietary recommendations. A patient homozygous for MTHFR C677T, for example, has approximately 70% reduced methylation capacity, necessitating methylfolate rather than folic acid supplementation.
Standard lipid panels (total cholesterol, LDL, HDL, triglycerides) provide limited cardiovascular risk assessment. Advanced panels incorporating LDL particle number, LDL particle size, lipoprotein(a), ApoB, and oxidised LDL offer substantially greater predictive value. A patient with "normal" LDL cholesterol but elevated LDL particle number and small dense LDL pattern carries significantly higher cardiovascular risk than standard testing would suggest.
IgG and IgA food sensitivity panels, whilst requiring careful clinical interpretation, can identify immune-mediated food reactions not captured by IgE allergy testing. These results should always be correlated with elimination-challenge protocols and symptom tracking. Array testing for intestinal permeability (zonulin, occludin, actomyosin antibodies) provides objective assessment of barrier function.
The value of advanced testing lies not in individual markers but in pattern recognition across multiple data points. A patient presenting with elevated hs-CRP, low vitamin D, high reverse T3, dysbiotic stool analysis, and MTHFR polymorphisms represents a coherent clinical picture of inflammation-driven thyroid dysfunction with impaired methylation — a pattern invisible to conventional screening.
At EPINUTRI, we integrate laboratory data within the Functional Health Matrix, mapping test results to the eight physiological nodes to create a comprehensive clinical picture. This systems-based interpretation enables practitioners to prioritise interventions and track progress objectively.
Testing without clinical context is data. Testing within a systems-based framework is intelligence. The practitioner's role is to transform one into the other.
For practitioners seeking to expand their testing repertoire, we recommend implementing Tier 1 panels universally, adding Tier 2 assessments based on clinical presentation, and reserving Tier 3 testing for complex or treatment-resistant cases. This tiered approach balances clinical thoroughness with cost-effectiveness for patients.
Tier 1 — Foundation panels (every patient at intake). CMP with fasting insulin, full thyroid panel (TSH, fT3, fT4, rT3, TPO, TG antibodies), full iron studies, hs-CRP, 25(OH)D, active B12, RBC magnesium. Indicative private-pay UK cost: £120–£220.
Tier 2 — Functional assessments (by clinical presentation). Organic Acids Test (OAT), comprehensive stool analysis with PCR pathogen detection, DUTCH cortisol and sex-hormone metabolites. Order when symptoms point to mitochondrial, GI, or HPA-axis involvement. Indicative cost: £250–£450 per panel.
Tier 3 — Specialised testing (complex or treatment-resistant cases). Nutrigenomic SNPs (MTHFR, COMT, VDR, APOE, FUT2, CYP450), advanced lipid (ApoB, LDL particle number, Lp(a), oxidised LDL), IgG/IgA food sensitivity panels, intestinal permeability array (zonulin, occludin). Indicative cost: £200–£500 per panel.
We have packaged the Tier 1, 2, and 3 model into a printable practitioner checklist with optimal ranges, clinical indications, and an ordering sequence designed to slot directly into your patient workup. Download the free testing checklist (PDF).
Written by
Medical disclaimer: The content in this article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any changes to your health regimen. Individual results may vary. If you are experiencing a medical emergency, please contact 999 immediately.
EPINUTRI is opening to Nutrition practitioners in our early cohort. Apply to integrate the Functional Health Matrix into your practice.

The Shifting Landscape of Dietary Guidance The 2025-2030 dietary guidelines represent a significant evolution in mainstream nutritional thinking, with several u...

Why Track Your Health? Health tracking transforms vague feelings into objective data. Rather than telling your GP "I've been feeling tired lately," you can show...

Understanding Chronic Inflammation Chronic low-grade inflammation is now recognised as a common thread linking many modern diseases, from cardiovascular disease...